TICKERNOMICS Sign up
Last Update: 2024-12-27 15:25:41
BlackRock Health Sciences Trust ( BME ) https://www.blackrock.com/investing/products/24022
38.47USD
Sector:
Financial Services
Industry:
Asset Management
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-3.12%
BME
SPY
32.66%
-18.21%
BME
SPY
108.59%
BME
5.13%
SPY
302.52%
BME
127.01%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
522.06
502.12
0.08
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
8.85
21.47
0.85
4.38
0.00
0.00
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
21.17
100.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.3008
-24.05
0.29
0.81
Other Earnings and Cash Flow Stats:
BlackRock Health Sciences Trust ( BME ) Net Income TTM ($MM) is 59.01
BlackRock Health Sciences Trust ( BME ) Operating Income TTM ($MM) is 9.98
BlackRock Health Sciences Trust ( BME ) Owners' Earnings Annual ($MM) is 0.00
BlackRock Health Sciences Trust ( BME ) Current Price to Owners' Earnings ratio is 0.00
BlackRock Health Sciences Trust ( BME ) EBITDA TTM ($MM) is 8.29
BlackRock Health Sciences Trust ( BME ) EBITDA Margin is 0.00%
Capital Allocation:
BlackRock Health Sciences Trust ( BME ) has paid 0.00 dividends per share and bought back 0.0 million shares in the past 12 months
BlackRock Health Sciences Trust ( BME ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
BlackRock Health Sciences Trust ( BME ) Interest-bearing Debt ($MM) as of last quarter is 0
BlackRock Health Sciences Trust ( BME ) Annual Working Capital Investments ($MM) are 11
BlackRock Health Sciences Trust ( BME ) Book Value ($MM) as of last quarter is 616
BlackRock Health Sciences Trust ( BME ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
BlackRock Health Sciences Trust ( BME ) has 0 million in cash on hand as of last quarter
BlackRock Health Sciences Trust ( BME ) has 9 million of liabilities due within 12 months, and long term debt 0 as of last quarter
BlackRock Health Sciences Trust ( BME ) has 13 common shares outstanding as of last quarter
BlackRock Health Sciences Trust ( BME ) has 0 million USD of preferred stock value
Academic Scores:
BlackRock Health Sciences Trust ( BME ) Altman Z-Score is 35.20 as of last quarter
BlackRock Health Sciences Trust ( BME ) Piotroski Score is 4.00 as of last quarter
Corporate Governance:
BlackRock Health Sciences Trust ( BME ) largest shareholder is Stifel Financial Corp owning 6137 shares at 0.24 ($MM) value
McClements Kyle(an insider) Bought 287.220703125 shares of BlackRock Health Sciences Trust ( BME ) for the amount of $0.00 on 2022-01-31
0.00% of BlackRock Health Sciences Trust ( BME ) is held by insiders, and 23.05% is held by institutions
BlackRock Health Sciences Trust ( BME ) went public on 2005-03-29
Other BlackRock Health Sciences Trust ( BME ) financial metrics:
FCF:24.97
Unlevered Free Cash Flow:0.00
EPS:6.59
Operating Margin:21.17
Gross Profit Margin:100.00
Div. Payout Ratio%:60.40
Div. Growth YoY%:0.00
Equity Return%:14.91
Beta:0.81
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About BlackRock Health Sciences Trust ( BME ) :
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.